Exact Sciences Stock Gross Profit

EXAS Stock

USD 60.10 1.59 2.58%

EXACT Sciences fundamentals help investors to digest information that contributes to EXACT Sciences' financial success or failures. It also enables traders to predict the movement of EXACT Stock. The fundamental analysis module provides a way to measure EXACT Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EXACT Sciences stock.

	Last Reported	Projected for Next Year
Gross Profit	1.8 B	1.9 B
Gross Profit Margin	0.74	0.76

Gross Profit is likely to gain to about 1.9 B in 2024. Gross Profit Margin is likely to gain to 0.76 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

EXACT Sciences Company Gross Profit Analysis

EXACT Sciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current EXACT Sciences Gross Profit

1.51 B

Most of EXACT Sciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EXACT Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

EXACT Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for EXACT Sciences is extremely important. It helps to project a fair market value of EXACT Stock properly, considering its historical fundamentals such as Gross Profit. Since EXACT Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EXACT Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EXACT Sciences' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Total Current Assets	Retained Earnings	Accounts Payable	Common Stock	Intangible Assets	Property Plant Equipment	Good Will	Short Term Investments	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Accumulated Depreciation	Short Term Debt	Net Receivables	Short Long Term Debt	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.99	0.9	0.99	0.79	-0.97	0.97	0.88	0.98	0.99	0.99	0.29	0.44	0.99	-0.02	0.98	0.99	-0.72	0.45	0.92	0.53	0.98	-0.55	0.53	0.99
Total Stockholder Equity	0.99		0.86	0.97	0.8	-0.94	0.94	0.89	0.96	0.98	0.97	0.27	0.5	0.96	-0.04	0.97	0.98	-0.75	0.49	0.94	0.56	0.98	-0.51	0.54	0.98
Net Debt	0.9	0.86		0.93	0.52	-0.92	0.95	0.77	0.95	0.93	0.94	0.3	0.24	0.94	-0.1	0.86	0.91	-0.58	0.04	0.71	0.14	0.87	-0.57	0.23	0.91
Total Liab	0.99	0.97	0.93		0.77	-0.98	0.98	0.86	0.97	0.99	0.98	0.31	0.38	1.0	0.0	0.98	0.99	-0.68	0.4	0.88	0.49	0.97	-0.59	0.52	0.99
Total Current Assets	0.79	0.8	0.52	0.77		-0.74	0.72	0.79	0.65	0.75	0.68	0.57	0.59	0.76	0.15	0.84	0.76	-0.77	0.76	0.87	0.81	0.79	-0.31	0.92	0.72
Retained Earnings	-0.97	-0.94	-0.92	-0.98	-0.74		-0.98	-0.9	-0.94	-0.96	-0.96	-0.29	-0.25	-0.98	-0.14	-0.96	-0.98	0.72	-0.37	-0.84	-0.45	-0.93	0.62	-0.47	-0.97
Accounts Payable	0.97	0.94	0.95	0.98	0.72	-0.98		0.87	0.96	0.98	0.96	0.34	0.29	0.99	0.07	0.96	0.98	-0.7	0.3	0.82	0.38	0.93	-0.63	0.46	0.96
Common Stock	0.88	0.89	0.77	0.86	0.79	-0.9	0.87		0.83	0.89	0.84	0.44	0.41	0.86	0.13	0.86	0.89	-0.88	0.39	0.82	0.45	0.84	-0.49	0.5	0.84
Intangible Assets	0.98	0.96	0.95	0.97	0.65	-0.94	0.96	0.83		0.98	1.0	0.2	0.39	0.97	-0.12	0.93	0.97	-0.64	0.28	0.86	0.37	0.96	-0.55	0.35	0.98
Property Plant Equipment	0.99	0.98	0.93	0.99	0.75	-0.96	0.98	0.89	0.98		0.98	0.31	0.41	0.99	-0.02	0.97	0.99	-0.73	0.36	0.88	0.43	0.96	-0.6	0.48	0.97
Good Will	0.99	0.97	0.94	0.98	0.68	-0.96	0.96	0.84	1.0	0.98		0.18	0.36	0.98	-0.06	0.96	0.98	-0.64	0.34	0.87	0.43	0.96	-0.59	0.4	0.99
Short Term Investments	0.29	0.27	0.3	0.31	0.57	-0.29	0.34	0.44	0.2	0.31	0.18		0.54	0.32	-0.11	0.29	0.24	-0.61	0.07	0.32	0.13	0.29	0.13	0.55	0.17
Current Deferred Revenue	0.44	0.5	0.24	0.38	0.59	-0.25	0.29	0.41	0.39	0.41	0.36	0.54		0.36	-0.62	0.39	0.33	-0.52	0.38	0.63	0.44	0.49	0.22	0.53	0.35
Long Term Debt	0.99	0.96	0.94	1.0	0.76	-0.98	0.99	0.86	0.97	0.99	0.98	0.32	0.36		0.02	0.98	0.99	-0.68	0.38	0.87	0.46	0.96	-0.6	0.52	0.98
Net Tangible Assets	-0.02	-0.04	-0.1	0.0	0.15	-0.14	0.07	0.13	-0.12	-0.02	-0.06	-0.11	-0.62	0.02		0.09	0.08	-0.12	0.31	-0.08	0.24	-0.06	-0.3	0.2	0.0
Long Term Debt Total	0.98	0.97	0.86	0.98	0.84	-0.96	0.96	0.86	0.93	0.97	0.96	0.29	0.39	0.98	0.09		0.98	-0.68	0.54	0.91	0.61	0.96	-0.59	0.63	0.97
Capital Surpluse	0.99	0.98	0.91	0.99	0.76	-0.98	0.98	0.89	0.97	0.99	0.98	0.24	0.33	0.99	0.08	0.98		-0.71	0.42	0.88	0.5	0.96	-0.64	0.5	0.99
Accumulated Depreciation	-0.72	-0.75	-0.58	-0.68	-0.77	0.72	-0.7	-0.88	-0.64	-0.73	-0.64	-0.61	-0.52	-0.68	-0.12	-0.68	-0.71		-0.37	-0.74	-0.42	-0.7	0.23	-0.53	-0.64
Short Term Debt	0.45	0.49	0.04	0.4	0.76	-0.37	0.3	0.39	0.28	0.36	0.34	0.07	0.38	0.38	0.31	0.54	0.42	-0.37		0.66	0.99	0.49	-0.09	0.81	0.43
Net Receivables	0.92	0.94	0.71	0.88	0.87	-0.84	0.82	0.82	0.86	0.88	0.87	0.32	0.63	0.87	-0.08	0.91	0.88	-0.74	0.66		0.72	0.96	-0.28	0.65	0.9
Short Long Term Debt	0.53	0.56	0.14	0.49	0.81	-0.45	0.38	0.45	0.37	0.43	0.43	0.13	0.44	0.46	0.24	0.61	0.5	-0.42	0.99	0.72		0.57	-0.1	0.84	0.51
Net Invested Capital	0.98	0.98	0.87	0.97	0.79	-0.93	0.93	0.84	0.96	0.96	0.96	0.29	0.49	0.96	-0.06	0.96	0.96	-0.7	0.49	0.96	0.57		-0.41	0.54	0.98
Long Term Investments	-0.55	-0.51	-0.57	-0.59	-0.31	0.62	-0.63	-0.49	-0.55	-0.6	-0.59	0.13	0.22	-0.6	-0.3	-0.59	-0.64	0.23	-0.09	-0.28	-0.1	-0.41		-0.2	-0.56
Net Working Capital	0.53	0.54	0.23	0.52	0.92	-0.47	0.46	0.5	0.35	0.48	0.4	0.55	0.53	0.52	0.2	0.63	0.5	-0.53	0.81	0.65	0.84	0.54	-0.2		0.45
Capital Stock	0.99	0.98	0.91	0.99	0.72	-0.97	0.96	0.84	0.98	0.97	0.99	0.17	0.35	0.98	0.0	0.97	0.99	-0.64	0.43	0.9	0.51	0.98	-0.56	0.45

Click cells to compare fundamentals

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict EXACT Sciences

Gross Profit Over Time

According to the company disclosure, EXACT Sciences reported 1.51 B of gross profit. This is 32.69% lower than that of the Biotechnology sector and 68.99% higher than that of the Health Care industry. The gross profit for all United States stocks is 94.48% higher than that of the company.

EXACT Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXACT Sciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics of similar companies.

EXACT Sciences is currently under evaluation in gross profit category among its peers.

EXACT Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EXACT Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EXACT Sciences' managers, analysts, and investors.

Environmental

Governance

Social

EXACT Fundamentals

	Return On Equity	-0.0676
	Return On Asset	-0.0216
	Profit Margin	(0.08) %
	Operating Margin	(0.03) %
	Current Valuation	12.86 B
	Shares Outstanding	185.08 M
	Shares Owned By Insiders	1.01 %
	Shares Owned By Institutions	98.99 %
	Number Of Shares Shorted	13.84 M
	Price To Earning	(38.17) X
	Price To Book	3.46 X
	Price To Sales	4.24 X
	Revenue	2.5 B
	Gross Profit	1.51 B
	EBITDA	41.88 M
	Net Income	(204.15 M)
	Cash And Equivalents	728.04 M
	Cash Per Share	4.11 X
	Total Debt	2.55 B
	Debt To Equity	0.77 %
	Current Ratio	2.48 X
	Book Value Per Share	17.35 X
	Cash Flow From Operations	156.12 M
	Short Ratio	4.59 X
	Earnings Per Share	(1.19) X
	Price To Earnings To Growth	(1.07) X
	Target Price	70.81
	Number Of Employees	6.5 K
	Beta	1.27
	Market Capitalization	11.42 B
	Total Asset	6.47 B
	Retained Earnings	(3.47 B)
	Working Capital	679.67 M
	Current Asset	325.86 M
	Current Liabilities	26.72 M
	Net Asset	6.47 B

About EXACT Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze EXACT Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC